Atrazine and Its Effects on Ovarian Cancer Cells
Author Information
Author(s): Lidia Albanito, Rosamaria Lappano, Antonio Madeo, Adele Chimento, Eric R. Prossnitz, Anna Rita Cappello, Vincenza Dolce, Sergio Abonante, Vincenzo Pezzi, Marcello Maggiolini
Primary Institution: Department of Pharmaco-Biology, University of Calabria, Rende, Italy
Hypothesis
Can atrazine signal through GPR30 to stimulate biological responses in ovarian cancer cells?
Conclusion
Atrazine stimulates the proliferation of ovarian cancer cells through the GPR30–EGFR pathway without activating the estrogen receptor.
Supporting Evidence
- Atrazine does not activate the estrogen receptor in cancer cells.
- Atrazine stimulates ERK phosphorylation in ovarian cancer cells.
- Atrazine induces the expression of estrogen target genes.
- The proliferation of ovarian cancer cells induced by atrazine requires GPR30 and ERα.
Takeaway
Atrazine, a common pesticide, can make certain cancer cells grow faster by using a different pathway than the usual estrogen receptor.
Methodology
The study used gene reporter assays, signaling inhibitors, and gene silencing to evaluate the effects of atrazine on ovarian cancer cells.
Limitations
The study primarily focused on specific cancer cell lines, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website